![[PRIVATE] 2022 AAD Annual Meeting Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/4/81c91c37-d0e3-4631-b2c2-69e9eb48f907.png.200x200_q85.png){kind=logo}
Off-Label Use of Biologics: Apremilast and Dupilumab
By
[PRIVATE] 2022 AAD Annual Meeting Coverage
FEATURING
David Rosmarin
By
[PRIVATE] 2022 AAD Annual Meeting Coverage
FEATURING
David Rosmarin
Login to view comments.
Click here to Login
